SlideShare a Scribd company logo
COVANCE MARKET ACCESS
Experience Forward Thinking
THE 7 ESSENTIALS
OF SUCCESSFUL
HEALTH ECONOMIC
COMMUNICATION
2
Why is good communication
of health economics so important?
In an era of continued pressure on healthcare budgets, the role of health economic data has
never been more important. Yet the contribution these data make to rational decision-making can
be undermined by incomprehension, skepticism and even hostility from outsiders – including
colleagues, commentators and healthcare decision-makers. What steps can be taken to address
the problem?
At Covance, we consider there to be 7 essentials for the successful communication of health
economic data. These are logical steps that can provide a framework for all communication
activities – both internally and externally – and can help ensure your audiences hear, understand
and act upon the information presented to them.
THE 7 ESSENTIALS
OF SUCCESSFUL
HEALTH ECONOMIC
COMMUNICATION
Define what you want to achieve
Identify your audience
Know your audience
Decide what to say
Say it appropriately
Make an impact
Tell a story
1
2
3
4
5
6
7
3
DEFINE WHAT YOU WANT TO ACHIEVE
At the start of any communication activity you need to be clear on your goals. What do
you want your audience to think or do as a result of what you tell them? For example, do
you want to:
▶▶ optimize reimbursement and uptake for a new technology?
▶▶ increase your colleagues’ understanding and appreciation of health economic data?
▶▶ secure additional funding for your department?
▶▶ demonstrate a novel approach to an analysis to your peers?
Your objectives will provide a focus for your communication – by knowing your goals
you can direct your activities towards achieving them.
IDENTIFY YOUR AUDIENCE
Having defined what you want to achieve, you need to work out who you need to
communicate with in order to reach your goals. Suppose you are trying to optimize
reimbursement and uptake for your company’s new technology – who might be
involved in decisions related to its market access? Within a single healthcare system
there may be hundreds, or even thousands, of stakeholders who make or influence
such decisions – for example, clinicians, pharmacists, medical directors, budget
holders, insurance plan managers, and other third-party payers. Beyond them,
employers, politicians, patients, and even the media can influence decision-making.
To add to this complexity, the identity of the audience can vary widely between
countries, and even between regions within a single country. Accordingly, identifying
the groups who need to be reached in order to achieve your goals can be challenging.
Nevertheless, it is a key stage in planning communication activities.
Who can
influence my
goals?
1.
2.
4
KNOW YOUR AUDIENCE
Having identified your audiences, you need to understand them – what do they consider to be
important when making decisions? If you are trying to optimize the usage of a product, you
will be communicating with audiences who will make judgments about the relative clinical and
economic value of the product. There are a number of product-related factors that they may take
into account when making this judgment, for example:
The relative importance of these decision drivers will vary between stakeholders. For example,
an HTA agency with a remit to assess the cost-effectiveness of products may focus on value for
money, while a pharmacist managing regional pharmacy budgets is likely to be more concerned
about the affordability of the product. When communicating with multiple stakeholders, you
need to be aware that they each have their own viewpoint, and will consider different factors when
making decisions.
DECIDE WHAT TO SAY
Deciding what to say to your audience involves tailoring your communications based on their
interests. For example, messages relating to cost-effectiveness may resonate with an HTA agency,
but be irrelevant to a regional budget holder.
It is also important to know what you want your audience to take away
from the communication – in other words, the message. By building
communication around messages, you can help ensure that evidence is
interpreted by your audience in the way you intend.
PRODUCT
VALUE:
Decision
Drivers
Political pressureClinical effectiveness
ExclusivitySafety
Value for moneyPatient impact
AffordabilityUnmet need
3.
4.
5
utility
utility
utility
sensitivity analysis
sensitivity analysis
adherence
adherence
discounting
discounting
cost consequence
cost consequence
QALY
QALY
QoL
QALY
direct costs
direct costs
QoL
prevalence
markov model
markov model
markov model
dominant
proindirect costs
cost utility
time trade-off
time trade-off
persistence
persistence
persistence
persistence
decision tree
decision tree cost benefit
cost benefit
cost benefit
perspectiveperspective incidence
incidence
SAY IT APPROPRIATELY
A key part of appropriate communication is to talk to audiences using terms
they understand. Many of the stakeholders to whom health economic evidence is
communicated will have little, if any, health economic training. As a result, audiences
may be unfamiliar with, or will misinterpret, specialist health economic terms. This
can make communication of health economic evidence challenging, but it doesn’t
mean you cannot communicate with your audiences. Rather, you need to consider
the language you use and ensure your audience will be able to understand what you
tell them. For example, without training in health economics, many stakeholders are
unlikely to understand what is meant if they are told that a new technology dominates
the current standard of care. However, if they are told that the product achieves better
clinical outcomes at a reduced cost compared to the current standard of care, the
interpretation of the information is clear.
Another aspect of appropriate communication relates to the choice of medium. There
are many channels through which audiences can be reached – manuscripts, HTA
submissions, field force activities, conferences, and websites – to name but a few.
In order to effectively communicate with an audience, you need to understand what
media they will respond to and will be exposed to – for example, there is little point in
presenting data on a website if the intended audience is unlikely to visit it.
Which terms
should I use?
5.
6
MAKE AN IMPACT
The most effective communication makes an impact and is clearly understood. Graphics,
rather than text, can often be the best way to convey data and can support the communication
of complex information, such as the design of a Markov model, or the results of a cost-utility
analysis. However, you need to ensure that graphics can be easily interpreted. This can often be
achieved through simple signposting – for example, by adding an arrow to indicate the positive
direction of change when using a patient-reported outcomes scale, or labelling the ends of an axis
showing a utility scale ‘perfect health’ and ‘death’.
Another way of optimizing impact is to remove information that is not required. When
developing any communication piece you should ask yourself ‘what can I delete?’. In some
cases a certain level of detail may be necessary – for example, the content of an HTA submission
needs to be thorough and robust. However, it is important to be able to distinguish between
the information that is necessary to convey a message, and information that detracts from clear
understanding of the message. As hard as it may be, you need to consider that the delete key
could be your best friend!
6.
Cost per QALY
vs standard care
($)
Treatment option
60,000
40,000
20,000
0
1 2 3 40
Cost-effectiveness threshold
Health state
value
Treatment X Standard care
Perfect health - 1
Death - 0
Death
Most
severe
Least
severe S1
S2
S3
S4
S5
S6
7
TELL A STORY
Audiences naturally respond to a story, and health economic evidence is best
communicated if structured as a narrative. This means that messages should be
presented as a logical, progressive series of ideas.
All types of communication can tell a story. For example, the conventional structure of
a manuscript forms a natural narrative – the introduction explains current knowledge
of a topic and the need for new research, which is followed by the methods used
and the results. Finally, the results are discussed in the context of the introduction.
Economic models can also be presented to tell a story. For example, inputs can
be entered in a logical, step-by-step manner before clearly signposted results are
presented. This approach makes models easier to understand which can, in turn, lead
to greater acceptance and understanding of the results by the audience.
By telling a story you can engage with an audience. If an audience is
engaged, it is more likely to listen to, and respond to, the messages
you are communicating. And, provided these messages have
been tailored to resonate with the audience, you are likely to
achieve the objectives you initially identified as the goals of your
communication.
7.
Covance is uniquely positioned to deliver solutions designed to dynamically
explore and unlock your compound’s market potential from discovery
through commercialization and beyond. Our Consulting experts partner
with you to transform data into actionable insights, revealing opportunities
to better build value.
Establish your product’s need in the marketplace and
communicate its value to the right decision-makers
through multiple communication tools and channels
Assess and identify the optimal connection between
products and markets
Generate compelling evidence to achieve optimal
market access and the best possible price for
your product
Define
strategy
Develop and
synthesize evidence
Communicate
value
COVANCE MARKET ACCESS
Experience Forward Thinking
www.covance.com/marketaccess
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory
Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the
marketing name for Covance Inc. and its subsidiaries around the world.
The Americas +1.888.COVANCE (+1.888.268.2623)  +1.609.452.4440
Europe / Africa  +00.800.2682.2682 +44.1423.500888
Asia Pacific  +800.6568.3000 +65.6.5686588
© Copyright 2018 Covance Inc. BROCMA010-0118

More Related Content

What's hot

How GVDs Need to Evolve
How GVDs Need to EvolveHow GVDs Need to Evolve
How GVDs Need to Evolve
Curo Consulting
 
Lovesac crm vision 062015
Lovesac crm vision 062015Lovesac crm vision 062015
Lovesac crm vision 062015
CRM Strategies, LLC
 
Beyond Omnichannel: Determining the Right Channel Mix
Beyond Omnichannel: Determining the Right Channel MixBeyond Omnichannel: Determining the Right Channel Mix
Beyond Omnichannel: Determining the Right Channel Mix
Cognizant
 
Great value propositions payer value delivered
Great value propositions payer value deliveredGreat value propositions payer value delivered
Great value propositions payer value delivered
Curo Consulting
 
Pay attention-final-report.pd
Pay attention-final-report.pdPay attention-final-report.pd
Pay attention-final-report.pd
Magazine Media Associatie
 
Media Mix Services
Media Mix ServicesMedia Mix Services
Media Mix ServicesThanas Goga
 
Managing the Social Media Mix
Managing the Social Media MixManaging the Social Media Mix
Managing the Social Media Mix
C.Y Wong
 
Combining Knowledge and Data Mining to Understand Sentiment
Combining Knowledge and Data Mining to Understand SentimentCombining Knowledge and Data Mining to Understand Sentiment
Combining Knowledge and Data Mining to Understand Sentiment
C.Y Wong
 
Top Five Metrics for Revenue Generation Marketers
Top Five Metrics for Revenue Generation MarketersTop Five Metrics for Revenue Generation Marketers
Top Five Metrics for Revenue Generation Marketers
C.Y Wong
 
What is the 1 to 1 experience?
What is the 1 to 1 experience?What is the 1 to 1 experience?
What is the 1 to 1 experience?
Fuji Xerox Singapore
 
The new pharma, customer centric, databased business model
The new pharma, customer centric, databased business modelThe new pharma, customer centric, databased business model
The new pharma, customer centric, databased business model
A.R.J. (Rob) Halkes
 
Ad Effectiveness and Performance - Life Insurance Dec 2007
Ad Effectiveness and Performance - Life Insurance Dec 2007Ad Effectiveness and Performance - Life Insurance Dec 2007
Ad Effectiveness and Performance - Life Insurance Dec 2007
JuxtConsult
 
Ad Effectiveness Study - Life Insurance Dec 2007
Ad Effectiveness Study - Life Insurance Dec 2007Ad Effectiveness Study - Life Insurance Dec 2007
Ad Effectiveness Study - Life Insurance Dec 2007
JuxtConsult
 
Measurement of what really counts emotions - paul roberts
Measurement of what really counts  emotions - paul robertsMeasurement of what really counts  emotions - paul roberts
Measurement of what really counts emotions - paul roberts
Merlien Institute
 
4 New Fundamentals for Medical Device Marketers
4 New Fundamentals for Medical Device Marketers4 New Fundamentals for Medical Device Marketers
4 New Fundamentals for Medical Device Marketers
Grey Matter Marketing
 
Vital Signs: Media measurement & engagement (Midia Master 2008)
Vital Signs: Media measurement & engagement (Midia Master 2008)Vital Signs: Media measurement & engagement (Midia Master 2008)
Vital Signs: Media measurement & engagement (Midia Master 2008)
Eleanor Stribling
 
Target-Engage-Support: The definitive guide to online customer interaction
Target-Engage-Support: The definitive guide to online customer interactionTarget-Engage-Support: The definitive guide to online customer interaction
Target-Engage-Support: The definitive guide to online customer interaction
Gianluca Ferranti
 
Social media measurement tools group 1
Social media measurement tools   group 1Social media measurement tools   group 1
Social media measurement tools group 1Sahil Surana
 

What's hot (20)

How GVDs Need to Evolve
How GVDs Need to EvolveHow GVDs Need to Evolve
How GVDs Need to Evolve
 
Lovesac crm vision 062015
Lovesac crm vision 062015Lovesac crm vision 062015
Lovesac crm vision 062015
 
Beyond Omnichannel: Determining the Right Channel Mix
Beyond Omnichannel: Determining the Right Channel MixBeyond Omnichannel: Determining the Right Channel Mix
Beyond Omnichannel: Determining the Right Channel Mix
 
Great value propositions payer value delivered
Great value propositions payer value deliveredGreat value propositions payer value delivered
Great value propositions payer value delivered
 
Bachelor in Marketing - UiS 2012
Bachelor in Marketing - UiS 2012Bachelor in Marketing - UiS 2012
Bachelor in Marketing - UiS 2012
 
Pay attention-final-report.pd
Pay attention-final-report.pdPay attention-final-report.pd
Pay attention-final-report.pd
 
Media Mix Services
Media Mix ServicesMedia Mix Services
Media Mix Services
 
Connect Champions Day October 2010
Connect Champions Day October 2010Connect Champions Day October 2010
Connect Champions Day October 2010
 
Managing the Social Media Mix
Managing the Social Media MixManaging the Social Media Mix
Managing the Social Media Mix
 
Combining Knowledge and Data Mining to Understand Sentiment
Combining Knowledge and Data Mining to Understand SentimentCombining Knowledge and Data Mining to Understand Sentiment
Combining Knowledge and Data Mining to Understand Sentiment
 
Top Five Metrics for Revenue Generation Marketers
Top Five Metrics for Revenue Generation MarketersTop Five Metrics for Revenue Generation Marketers
Top Five Metrics for Revenue Generation Marketers
 
What is the 1 to 1 experience?
What is the 1 to 1 experience?What is the 1 to 1 experience?
What is the 1 to 1 experience?
 
The new pharma, customer centric, databased business model
The new pharma, customer centric, databased business modelThe new pharma, customer centric, databased business model
The new pharma, customer centric, databased business model
 
Ad Effectiveness and Performance - Life Insurance Dec 2007
Ad Effectiveness and Performance - Life Insurance Dec 2007Ad Effectiveness and Performance - Life Insurance Dec 2007
Ad Effectiveness and Performance - Life Insurance Dec 2007
 
Ad Effectiveness Study - Life Insurance Dec 2007
Ad Effectiveness Study - Life Insurance Dec 2007Ad Effectiveness Study - Life Insurance Dec 2007
Ad Effectiveness Study - Life Insurance Dec 2007
 
Measurement of what really counts emotions - paul roberts
Measurement of what really counts  emotions - paul robertsMeasurement of what really counts  emotions - paul roberts
Measurement of what really counts emotions - paul roberts
 
4 New Fundamentals for Medical Device Marketers
4 New Fundamentals for Medical Device Marketers4 New Fundamentals for Medical Device Marketers
4 New Fundamentals for Medical Device Marketers
 
Vital Signs: Media measurement & engagement (Midia Master 2008)
Vital Signs: Media measurement & engagement (Midia Master 2008)Vital Signs: Media measurement & engagement (Midia Master 2008)
Vital Signs: Media measurement & engagement (Midia Master 2008)
 
Target-Engage-Support: The definitive guide to online customer interaction
Target-Engage-Support: The definitive guide to online customer interactionTarget-Engage-Support: The definitive guide to online customer interaction
Target-Engage-Support: The definitive guide to online customer interaction
 
Social media measurement tools group 1
Social media measurement tools   group 1Social media measurement tools   group 1
Social media measurement tools group 1
 

Similar to 7 Essentials of Health Economic Communication | Market Access Services

The 2018 Marketing Playbook
The 2018 Marketing PlaybookThe 2018 Marketing Playbook
The 2018 Marketing Playbook
Ogilvy Health
 
Running Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docx
Running Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docxRunning Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docx
Running Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docx
todd271
 
SPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
SPI Insight: Taking the Pulse of Big Changes in Healthcare SalesSPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
SPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
Dario Priolo
 
Getting More from Measurement - How to Demonstrate Marketing Returns and Make...
Getting More from Measurement - How to Demonstrate Marketing Returns and Make...Getting More from Measurement - How to Demonstrate Marketing Returns and Make...
Getting More from Measurement - How to Demonstrate Marketing Returns and Make...
Endeavor Management
 
Five People Based Marketing Strategies for 2016
Five People Based Marketing Strategies for 2016Five People Based Marketing Strategies for 2016
Five People Based Marketing Strategies for 2016
Merkle, A Performance Marketing Agency
 
Marketing 360 Evaluating Your Plan
Marketing 360 Evaluating Your PlanMarketing 360 Evaluating Your Plan
Marketing 360 Evaluating Your Plan
bob musilek
 
Mastery of Press Release Distribution Strategies.pptx
Mastery of Press Release Distribution Strategies.pptxMastery of Press Release Distribution Strategies.pptx
Mastery of Press Release Distribution Strategies.pptx
PRDistributionServic
 
Mh0056 public relations & marketing for healthcare organizations
Mh0056   public relations & marketing for healthcare organizationsMh0056   public relations & marketing for healthcare organizations
Mh0056 public relations & marketing for healthcare organizations
smumbahelp
 
Trends From The Trenches - Consumer Data, Insights and Innovation
Trends From The Trenches - Consumer Data, Insights and InnovationTrends From The Trenches - Consumer Data, Insights and Innovation
Trends From The Trenches - Consumer Data, Insights and Innovation
Andrea Simon
 
Repurposing: How to Get the Most of Your Content.pdf
Repurposing: How to Get the Most of Your Content.pdfRepurposing: How to Get the Most of Your Content.pdf
Repurposing: How to Get the Most of Your Content.pdf
Golin
 
Pm360 article results the future of pharma marketing
Pm360 article   results  the future of pharma marketingPm360 article   results  the future of pharma marketing
Pm360 article results the future of pharma marketing
Joanne Toran McHugh
 
Commercially Effective MCM
Commercially Effective MCMCommercially Effective MCM
Commercially Effective MCMAine Devane
 
Pharma Market Research Report Dec 2013
Pharma Market Research Report Dec 2013Pharma Market Research Report Dec 2013
Pharma Market Research Report Dec 2013
Brian Attig
 
Project TitlePROJECT TITLE Deployment of complete Open Sou.docx
Project TitlePROJECT TITLE Deployment of complete Open Sou.docxProject TitlePROJECT TITLE Deployment of complete Open Sou.docx
Project TitlePROJECT TITLE Deployment of complete Open Sou.docx
briancrawford30935
 
Funderburk field et al communicating with consumers nchcmm 8 11-11
Funderburk field et al communicating with consumers nchcmm 8 11-11Funderburk field et al communicating with consumers nchcmm 8 11-11
Funderburk field et al communicating with consumers nchcmm 8 11-11
Frank Funderburk
 
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
No Fixed Address Health
 
HealthCare Marketing Guide 2016
HealthCare Marketing Guide 2016HealthCare Marketing Guide 2016
HealthCare Marketing Guide 2016Djpakhs Pakhuongte
 
Where does pharma marketing go from here
Where does pharma marketing go from hereWhere does pharma marketing go from here
Where does pharma marketing go from here
Richard Meyer
 
7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docx7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docx
robert345678
 
Placing Customer Centricity at the Heart of Healthcare
Placing Customer Centricity at the Heart of HealthcarePlacing Customer Centricity at the Heart of Healthcare
Placing Customer Centricity at the Heart of Healthcare
1to1 Media
 

Similar to 7 Essentials of Health Economic Communication | Market Access Services (20)

The 2018 Marketing Playbook
The 2018 Marketing PlaybookThe 2018 Marketing Playbook
The 2018 Marketing Playbook
 
Running Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docx
Running Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docxRunning Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docx
Running Head DEVLOPING A STRATEGIC APPROACH 1DEVLOPING A STR.docx
 
SPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
SPI Insight: Taking the Pulse of Big Changes in Healthcare SalesSPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
SPI Insight: Taking the Pulse of Big Changes in Healthcare Sales
 
Getting More from Measurement - How to Demonstrate Marketing Returns and Make...
Getting More from Measurement - How to Demonstrate Marketing Returns and Make...Getting More from Measurement - How to Demonstrate Marketing Returns and Make...
Getting More from Measurement - How to Demonstrate Marketing Returns and Make...
 
Five People Based Marketing Strategies for 2016
Five People Based Marketing Strategies for 2016Five People Based Marketing Strategies for 2016
Five People Based Marketing Strategies for 2016
 
Marketing 360 Evaluating Your Plan
Marketing 360 Evaluating Your PlanMarketing 360 Evaluating Your Plan
Marketing 360 Evaluating Your Plan
 
Mastery of Press Release Distribution Strategies.pptx
Mastery of Press Release Distribution Strategies.pptxMastery of Press Release Distribution Strategies.pptx
Mastery of Press Release Distribution Strategies.pptx
 
Mh0056 public relations & marketing for healthcare organizations
Mh0056   public relations & marketing for healthcare organizationsMh0056   public relations & marketing for healthcare organizations
Mh0056 public relations & marketing for healthcare organizations
 
Trends From The Trenches - Consumer Data, Insights and Innovation
Trends From The Trenches - Consumer Data, Insights and InnovationTrends From The Trenches - Consumer Data, Insights and Innovation
Trends From The Trenches - Consumer Data, Insights and Innovation
 
Repurposing: How to Get the Most of Your Content.pdf
Repurposing: How to Get the Most of Your Content.pdfRepurposing: How to Get the Most of Your Content.pdf
Repurposing: How to Get the Most of Your Content.pdf
 
Pm360 article results the future of pharma marketing
Pm360 article   results  the future of pharma marketingPm360 article   results  the future of pharma marketing
Pm360 article results the future of pharma marketing
 
Commercially Effective MCM
Commercially Effective MCMCommercially Effective MCM
Commercially Effective MCM
 
Pharma Market Research Report Dec 2013
Pharma Market Research Report Dec 2013Pharma Market Research Report Dec 2013
Pharma Market Research Report Dec 2013
 
Project TitlePROJECT TITLE Deployment of complete Open Sou.docx
Project TitlePROJECT TITLE Deployment of complete Open Sou.docxProject TitlePROJECT TITLE Deployment of complete Open Sou.docx
Project TitlePROJECT TITLE Deployment of complete Open Sou.docx
 
Funderburk field et al communicating with consumers nchcmm 8 11-11
Funderburk field et al communicating with consumers nchcmm 8 11-11Funderburk field et al communicating with consumers nchcmm 8 11-11
Funderburk field et al communicating with consumers nchcmm 8 11-11
 
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
 
HealthCare Marketing Guide 2016
HealthCare Marketing Guide 2016HealthCare Marketing Guide 2016
HealthCare Marketing Guide 2016
 
Where does pharma marketing go from here
Where does pharma marketing go from hereWhere does pharma marketing go from here
Where does pharma marketing go from here
 
7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docx7IHP 510 Milestone Three Marketing and Communic.docx
7IHP 510 Milestone Three Marketing and Communic.docx
 
Placing Customer Centricity at the Heart of Healthcare
Placing Customer Centricity at the Heart of HealthcarePlacing Customer Centricity at the Heart of Healthcare
Placing Customer Centricity at the Heart of Healthcare
 

More from Covance

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Covance
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
Covance
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Covance
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
Covance
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
Covance
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
Covance
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
Covance
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
Covance
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
Covance
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
Covance
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
Covance
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Covance
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Covance
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Covance
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Covance
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
Covance
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
Covance
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
Covance
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
Covance
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
Covance
 

More from Covance (20)

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
 

Recently uploaded

Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
SwastikAyurveda
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 

Recently uploaded (20)

Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 

7 Essentials of Health Economic Communication | Market Access Services

  • 1. COVANCE MARKET ACCESS Experience Forward Thinking THE 7 ESSENTIALS OF SUCCESSFUL HEALTH ECONOMIC COMMUNICATION
  • 2. 2 Why is good communication of health economics so important? In an era of continued pressure on healthcare budgets, the role of health economic data has never been more important. Yet the contribution these data make to rational decision-making can be undermined by incomprehension, skepticism and even hostility from outsiders – including colleagues, commentators and healthcare decision-makers. What steps can be taken to address the problem? At Covance, we consider there to be 7 essentials for the successful communication of health economic data. These are logical steps that can provide a framework for all communication activities – both internally and externally – and can help ensure your audiences hear, understand and act upon the information presented to them. THE 7 ESSENTIALS OF SUCCESSFUL HEALTH ECONOMIC COMMUNICATION Define what you want to achieve Identify your audience Know your audience Decide what to say Say it appropriately Make an impact Tell a story 1 2 3 4 5 6 7
  • 3. 3 DEFINE WHAT YOU WANT TO ACHIEVE At the start of any communication activity you need to be clear on your goals. What do you want your audience to think or do as a result of what you tell them? For example, do you want to: ▶▶ optimize reimbursement and uptake for a new technology? ▶▶ increase your colleagues’ understanding and appreciation of health economic data? ▶▶ secure additional funding for your department? ▶▶ demonstrate a novel approach to an analysis to your peers? Your objectives will provide a focus for your communication – by knowing your goals you can direct your activities towards achieving them. IDENTIFY YOUR AUDIENCE Having defined what you want to achieve, you need to work out who you need to communicate with in order to reach your goals. Suppose you are trying to optimize reimbursement and uptake for your company’s new technology – who might be involved in decisions related to its market access? Within a single healthcare system there may be hundreds, or even thousands, of stakeholders who make or influence such decisions – for example, clinicians, pharmacists, medical directors, budget holders, insurance plan managers, and other third-party payers. Beyond them, employers, politicians, patients, and even the media can influence decision-making. To add to this complexity, the identity of the audience can vary widely between countries, and even between regions within a single country. Accordingly, identifying the groups who need to be reached in order to achieve your goals can be challenging. Nevertheless, it is a key stage in planning communication activities. Who can influence my goals? 1. 2.
  • 4. 4 KNOW YOUR AUDIENCE Having identified your audiences, you need to understand them – what do they consider to be important when making decisions? If you are trying to optimize the usage of a product, you will be communicating with audiences who will make judgments about the relative clinical and economic value of the product. There are a number of product-related factors that they may take into account when making this judgment, for example: The relative importance of these decision drivers will vary between stakeholders. For example, an HTA agency with a remit to assess the cost-effectiveness of products may focus on value for money, while a pharmacist managing regional pharmacy budgets is likely to be more concerned about the affordability of the product. When communicating with multiple stakeholders, you need to be aware that they each have their own viewpoint, and will consider different factors when making decisions. DECIDE WHAT TO SAY Deciding what to say to your audience involves tailoring your communications based on their interests. For example, messages relating to cost-effectiveness may resonate with an HTA agency, but be irrelevant to a regional budget holder. It is also important to know what you want your audience to take away from the communication – in other words, the message. By building communication around messages, you can help ensure that evidence is interpreted by your audience in the way you intend. PRODUCT VALUE: Decision Drivers Political pressureClinical effectiveness ExclusivitySafety Value for moneyPatient impact AffordabilityUnmet need 3. 4.
  • 5. 5 utility utility utility sensitivity analysis sensitivity analysis adherence adherence discounting discounting cost consequence cost consequence QALY QALY QoL QALY direct costs direct costs QoL prevalence markov model markov model markov model dominant proindirect costs cost utility time trade-off time trade-off persistence persistence persistence persistence decision tree decision tree cost benefit cost benefit cost benefit perspectiveperspective incidence incidence SAY IT APPROPRIATELY A key part of appropriate communication is to talk to audiences using terms they understand. Many of the stakeholders to whom health economic evidence is communicated will have little, if any, health economic training. As a result, audiences may be unfamiliar with, or will misinterpret, specialist health economic terms. This can make communication of health economic evidence challenging, but it doesn’t mean you cannot communicate with your audiences. Rather, you need to consider the language you use and ensure your audience will be able to understand what you tell them. For example, without training in health economics, many stakeholders are unlikely to understand what is meant if they are told that a new technology dominates the current standard of care. However, if they are told that the product achieves better clinical outcomes at a reduced cost compared to the current standard of care, the interpretation of the information is clear. Another aspect of appropriate communication relates to the choice of medium. There are many channels through which audiences can be reached – manuscripts, HTA submissions, field force activities, conferences, and websites – to name but a few. In order to effectively communicate with an audience, you need to understand what media they will respond to and will be exposed to – for example, there is little point in presenting data on a website if the intended audience is unlikely to visit it. Which terms should I use? 5.
  • 6. 6 MAKE AN IMPACT The most effective communication makes an impact and is clearly understood. Graphics, rather than text, can often be the best way to convey data and can support the communication of complex information, such as the design of a Markov model, or the results of a cost-utility analysis. However, you need to ensure that graphics can be easily interpreted. This can often be achieved through simple signposting – for example, by adding an arrow to indicate the positive direction of change when using a patient-reported outcomes scale, or labelling the ends of an axis showing a utility scale ‘perfect health’ and ‘death’. Another way of optimizing impact is to remove information that is not required. When developing any communication piece you should ask yourself ‘what can I delete?’. In some cases a certain level of detail may be necessary – for example, the content of an HTA submission needs to be thorough and robust. However, it is important to be able to distinguish between the information that is necessary to convey a message, and information that detracts from clear understanding of the message. As hard as it may be, you need to consider that the delete key could be your best friend! 6. Cost per QALY vs standard care ($) Treatment option 60,000 40,000 20,000 0 1 2 3 40 Cost-effectiveness threshold Health state value Treatment X Standard care Perfect health - 1 Death - 0 Death Most severe Least severe S1 S2 S3 S4 S5 S6
  • 7. 7 TELL A STORY Audiences naturally respond to a story, and health economic evidence is best communicated if structured as a narrative. This means that messages should be presented as a logical, progressive series of ideas. All types of communication can tell a story. For example, the conventional structure of a manuscript forms a natural narrative – the introduction explains current knowledge of a topic and the need for new research, which is followed by the methods used and the results. Finally, the results are discussed in the context of the introduction. Economic models can also be presented to tell a story. For example, inputs can be entered in a logical, step-by-step manner before clearly signposted results are presented. This approach makes models easier to understand which can, in turn, lead to greater acceptance and understanding of the results by the audience. By telling a story you can engage with an audience. If an audience is engaged, it is more likely to listen to, and respond to, the messages you are communicating. And, provided these messages have been tailored to resonate with the audience, you are likely to achieve the objectives you initially identified as the goals of your communication. 7.
  • 8. Covance is uniquely positioned to deliver solutions designed to dynamically explore and unlock your compound’s market potential from discovery through commercialization and beyond. Our Consulting experts partner with you to transform data into actionable insights, revealing opportunities to better build value. Establish your product’s need in the marketplace and communicate its value to the right decision-makers through multiple communication tools and channels Assess and identify the optimal connection between products and markets Generate compelling evidence to achieve optimal market access and the best possible price for your product Define strategy Develop and synthesize evidence Communicate value COVANCE MARKET ACCESS Experience Forward Thinking www.covance.com/marketaccess Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world. The Americas +1.888.COVANCE (+1.888.268.2623)  +1.609.452.4440 Europe / Africa  +00.800.2682.2682 +44.1423.500888 Asia Pacific  +800.6568.3000 +65.6.5686588 © Copyright 2018 Covance Inc. BROCMA010-0118